52584-286-35 |
52584-286 |
HUMAN PRESCRIPTION DRUG |
NAROPIN |
ropivacaine hydrochloride |
INJECTION, SOLUTION |
EPIDURAL; INFILTRATION; PERINEURAL |
20140311 |
20250930 |
NDA |
NDA020533 |
General Injectables & Vaccines, Inc |
ROPIVACAINE HYDROCHLORIDE |
5 mg/mL |
1 VIAL, SINGLE-DOSE in 1 BAG (52584-286-35) / 30 mL in 1 VIAL, SINGLE-DOSE |
0404-9924-30 |
0404-9924 |
HUMAN PRESCRIPTION DRUG |
NAROPIN |
ropivacaine hydrochloride |
INJECTION, SOLUTION |
EPIDURAL; INFILTRATION; PERINEURAL |
20220113 |
N/A |
NDA |
NDA020533 |
Henry Schein, Inc. |
ROPIVACAINE HYDROCHLORIDE |
5 mg/mL |
1 VIAL, SINGLE-DOSE in 1 BAG (0404-9924-30) / 30 mL in 1 VIAL, SINGLE-DOSE |
63323-285-68 |
63323-285 |
HUMAN PRESCRIPTION DRUG |
Naropin |
ROPIVACAINE HYDROCHLORIDE |
INJECTION, SOLUTION |
EPIDURAL; INFILTRATION |
20090804 |
N/A |
NDA |
NDA020533 |
Fresenius Kabi USA, LLC |
ROPIVACAINE HYDROCHLORIDE |
2 mg/mL |
12 BOTTLE in 1 CASE (63323-285-68) / 100 mL in 1 BOTTLE (63323-285-53) |
63323-285-10 |
63323-285 |
HUMAN PRESCRIPTION DRUG |
Naropin |
ROPIVACAINE HYDROCHLORIDE |
INJECTION, SOLUTION |
EPIDURAL; INFILTRATION |
20110531 |
N/A |
NDA |
NDA020533 |
Fresenius Kabi USA, LLC |
ROPIVACAINE HYDROCHLORIDE |
2 mg/mL |
5 AMPULE in 1 BOX (63323-285-10) / 10 mL in 1 AMPULE (63323-285-01) |
63323-285-13 |
63323-285 |
HUMAN PRESCRIPTION DRUG |
Naropin |
ROPIVACAINE HYDROCHLORIDE |
INJECTION, SOLUTION |
EPIDURAL; INFILTRATION |
20110531 |
N/A |
NDA |
NDA020533 |
Fresenius Kabi USA, LLC |
ROPIVACAINE HYDROCHLORIDE |
2 mg/mL |
25 VIAL, SINGLE-DOSE in 1 CARTON (63323-285-13) / 10 mL in 1 VIAL, SINGLE-DOSE (63323-285-03) |
63323-285-20 |
63323-285 |
HUMAN PRESCRIPTION DRUG |
Naropin |
ROPIVACAINE HYDROCHLORIDE |
INJECTION, SOLUTION |
EPIDURAL; INFILTRATION |
20110531 |
N/A |
NDA |
NDA020533 |
Fresenius Kabi USA, LLC |
ROPIVACAINE HYDROCHLORIDE |
2 mg/mL |
5 AMPULE in 1 BOX (63323-285-20) / 20 mL in 1 AMPULE (63323-285-06) |
63323-285-23 |
63323-285 |
HUMAN PRESCRIPTION DRUG |
Naropin |
ROPIVACAINE HYDROCHLORIDE |
INJECTION, SOLUTION |
EPIDURAL; INFILTRATION |
20110531 |
N/A |
NDA |
NDA020533 |
Fresenius Kabi USA, LLC |
ROPIVACAINE HYDROCHLORIDE |
2 mg/mL |
25 VIAL, SINGLE-DOSE in 1 CARTON (63323-285-23) / 20 mL in 1 VIAL, SINGLE-DOSE (63323-285-07) |
63323-285-61 |
63323-285 |
HUMAN PRESCRIPTION DRUG |
Naropin |
ROPIVACAINE HYDROCHLORIDE |
INJECTION, SOLUTION |
EPIDURAL; INFILTRATION |
20110531 |
N/A |
NDA |
NDA020533 |
Fresenius Kabi USA, LLC |
ROPIVACAINE HYDROCHLORIDE |
2 mg/mL |
24 BAG in 1 CASE (63323-285-61) / 100 mL in 1 BAG (63323-285-02) |
63323-285-63 |
63323-285 |
HUMAN PRESCRIPTION DRUG |
Naropin |
ROPIVACAINE HYDROCHLORIDE |
INJECTION, SOLUTION |
EPIDURAL; INFILTRATION |
20110531 |
N/A |
NDA |
NDA020533 |
Fresenius Kabi USA, LLC |
ROPIVACAINE HYDROCHLORIDE |
2 mg/mL |
24 BAG in 1 CASE (63323-285-63) / 200 mL in 1 BAG (63323-285-04) |
63323-285-64 |
63323-285 |
HUMAN PRESCRIPTION DRUG |
Naropin |
ROPIVACAINE HYDROCHLORIDE |
INJECTION, SOLUTION |
EPIDURAL; INFILTRATION |
20110531 |
N/A |
NDA |
NDA020533 |
Fresenius Kabi USA, LLC |
ROPIVACAINE HYDROCHLORIDE |
2 mg/mL |
12 BOTTLE in 1 CASE (63323-285-64) / 200 mL in 1 BOTTLE (63323-285-57) |
63323-285-65 |
63323-285 |
HUMAN PRESCRIPTION DRUG |
Naropin |
ROPIVACAINE HYDROCHLORIDE |
INJECTION, SOLUTION |
EPIDURAL; INFILTRATION |
20110531 |
N/A |
NDA |
NDA020533 |
Fresenius Kabi USA, LLC |
ROPIVACAINE HYDROCHLORIDE |
2 mg/mL |
12 BOTTLE in 1 CASE (63323-285-65) / 100 mL in 1 BOTTLE (63323-285-51) |
63323-286-27 |
63323-286 |
HUMAN PRESCRIPTION DRUG |
Naropin |
ROPIVACAINE HYDROCHLORIDE |
INJECTION, SOLUTION |
EPIDURAL; INFILTRATION; PERINEURAL |
20090804 |
N/A |
NDA |
NDA020533 |
Fresenius Kabi USA, LLC |
ROPIVACAINE HYDROCHLORIDE |
5 mg/mL |
25 VIAL, SINGLE-DOSE in 1 CARTON (63323-286-27) / 20 mL in 1 VIAL, SINGLE-DOSE (63323-286-41) |
63323-286-38 |
63323-286 |
HUMAN PRESCRIPTION DRUG |
Naropin |
ROPIVACAINE HYDROCHLORIDE |
INJECTION, SOLUTION |
EPIDURAL; INFILTRATION; PERINEURAL |
20090804 |
N/A |
NDA |
NDA020533 |
Fresenius Kabi USA, LLC |
ROPIVACAINE HYDROCHLORIDE |
5 mg/mL |
25 VIAL, SINGLE-DOSE in 1 CARTON (63323-286-38) / 30 mL in 1 VIAL, SINGLE-DOSE (63323-286-43) |
63323-286-95 |
63323-286 |
HUMAN PRESCRIPTION DRUG |
Naropin |
ROPIVACAINE HYDROCHLORIDE |
INJECTION, SOLUTION |
EPIDURAL; INFILTRATION; PERINEURAL |
20090804 |
N/A |
NDA |
NDA020533 |
Fresenius Kabi USA, LLC |
ROPIVACAINE HYDROCHLORIDE |
5 mg/mL |
25 VIAL, SINGLE-DOSE in 1 CARTON (63323-286-95) / 30 mL in 1 VIAL, SINGLE-DOSE (63323-286-93) |
63323-286-00 |
63323-286 |
HUMAN PRESCRIPTION DRUG |
Naropin |
ROPIVACAINE HYDROCHLORIDE |
INJECTION, SOLUTION |
EPIDURAL; INFILTRATION; PERINEURAL |
20110531 |
N/A |
NDA |
NDA020533 |
Fresenius Kabi USA, LLC |
ROPIVACAINE HYDROCHLORIDE |
5 mg/mL |
12 BOTTLE in 1 CASE (63323-286-00) / 100 mL in 1 BOTTLE (63323-286-03) |
63323-286-20 |
63323-286 |
HUMAN PRESCRIPTION DRUG |
Naropin |
ROPIVACAINE HYDROCHLORIDE |
INJECTION, SOLUTION |
EPIDURAL; INFILTRATION; PERINEURAL |
20110531 |
N/A |
NDA |
NDA020533 |
Fresenius Kabi USA, LLC |
ROPIVACAINE HYDROCHLORIDE |
5 mg/mL |
5 AMPULE in 1 BOX (63323-286-20) / 20 mL in 1 AMPULE (63323-286-01) |
63323-286-23 |
63323-286 |
HUMAN PRESCRIPTION DRUG |
Naropin |
ROPIVACAINE HYDROCHLORIDE |
INJECTION, SOLUTION |
EPIDURAL; INFILTRATION; PERINEURAL |
20110531 |
N/A |
NDA |
NDA020533 |
Fresenius Kabi USA, LLC |
ROPIVACAINE HYDROCHLORIDE |
5 mg/mL |
25 VIAL, SINGLE-DOSE in 1 CARTON (63323-286-23) / 20 mL in 1 VIAL, SINGLE-DOSE (63323-286-05) |
63323-286-30 |
63323-286 |
HUMAN PRESCRIPTION DRUG |
Naropin |
ROPIVACAINE HYDROCHLORIDE |
INJECTION, SOLUTION |
EPIDURAL; INFILTRATION; PERINEURAL |
20110531 |
N/A |
NDA |
NDA020533 |
Fresenius Kabi USA, LLC |
ROPIVACAINE HYDROCHLORIDE |
5 mg/mL |
1 VIAL, SINGLE-DOSE in 1 BOX (63323-286-30) / 30 mL in 1 VIAL, SINGLE-DOSE |
63323-286-31 |
63323-286 |
HUMAN PRESCRIPTION DRUG |
Naropin |
ROPIVACAINE HYDROCHLORIDE |
INJECTION, SOLUTION |
EPIDURAL; INFILTRATION; PERINEURAL |
20110531 |
N/A |
NDA |
NDA020533 |
Fresenius Kabi USA, LLC |
ROPIVACAINE HYDROCHLORIDE |
5 mg/mL |
5 VIAL, SINGLE-DOSE in 1 BOX (63323-286-31) / 30 mL in 1 VIAL, SINGLE-DOSE (63323-286-09) |
63323-286-35 |
63323-286 |
HUMAN PRESCRIPTION DRUG |
Naropin |
ROPIVACAINE HYDROCHLORIDE |
INJECTION, SOLUTION |
EPIDURAL; INFILTRATION; PERINEURAL |
20110531 |
N/A |
NDA |
NDA020533 |
Fresenius Kabi USA, LLC |
ROPIVACAINE HYDROCHLORIDE |
5 mg/mL |
25 VIAL, SINGLE-DOSE in 1 CARTON (63323-286-35) / 30 mL in 1 VIAL, SINGLE-DOSE (63323-286-11) |